Feature

May 01, 2026

What Is the Optimal Setting for T-DXd in Early Breast Cancer? Experts Debate

Trastuzumab deruxtecan (T-DXd) has claimed a large share of the HER2-positive breast cancer landscape, even finding room among tumors previously thought to be HER2-negative. The DESTINY series of tria...

The ASCO Post

April 30, 2026

What Is the Optimal Setting for T-DXd in Early Breast Cancer? Experts Differ

The ASCO Post

April 30, 2026

What Is the Optimal Setting for T-DXd in Early Breast Cancer? Experts Differ

The ASCO Post

April 28, 2026

Tracking Biological Age Changes Gives Insights Into Cancer Prognosis

Face aging rate, a measure of changes in biological age over time, could serve as a noninvasive prognostic biomarker for determining outcomes in patients with cancer, according to the results of a stu...

The ASCO Post

April 28, 2026

Tracking Biological Age Changes Gives Insights Into Cancer Prognosis

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

April 24, 2026

Dietary Influence on Leukemia and Lymphoma Progression

In 2015, LH, a 66-year-old female, was diagnosed with chronic lymphocytic leukemia (CLL), Rai stage 0. Untreated, the woman’s lymphocyte count rose from 5,000/mm3 to 16,000/mm3 in 6 years (doubling ti...

The ASCO Post

April 24, 2026

AI As Collaborator in Cancer Research and in Clinical Care

Last October, the Cancer AI Alliance (CAIA) announced the launch of its collaborative artificial intelligence (AI) platform powered by federated learning to train AI models with millions of de-identif...

The ASCO Post

April 24, 2026

Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center

An international leader in blood cancer and stem cell research has been named Director of the Montefiore Einstein Comprehensive Cancer Center and Vice President of Cancer Medicine at Montefiore Einste...

The ASCO Post

April 24, 2026

Dietary Influence on Leukemia and Lymphoma Progression

The ASCO Post

April 24, 2026

Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center

The ASCO Post

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Feature

What Is the Optimal Setting for T-DXd in Early Breast Cancer? Experts Debate

What Is the Optimal Setting for T-DXd in Early Breast Cancer? Experts Differ

What Is the Optimal Setting for T-DXd in Early Breast Cancer? Experts Differ

Tracking Biological Age Changes Gives Insights Into Cancer Prognosis

Tracking Biological Age Changes Gives Insights Into Cancer Prognosis

Daily News

Dietary Influence on Leukemia and Lymphoma Progression

AI As Collaborator in Cancer Research and in Clinical Care

Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center

Dietary Influence on Leukemia and Lymphoma Progression

Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

Feature

Daily News

Recommendations